Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization

Blood

Volumn 112, Issue 9, 2008, Pages 3638-3649

  Kawamura, Harukiyo ^a   Li, Xiujuan ^e   Goishi, Katsutoshi ^b   Van Meeteren, Laurens A ^a   Jakobsson, Lars ^a   Cébe Suarez, Stéphanie ^c   Shimizu, Akio ^b   Edholm, Dan ^a   Ballmer Hofer, Kurt ^c   Kjellén, Lena ^d   Klagsbrun, Michael ^b   Claesson Welsh, Lena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PAUL SCHERRER INSTITUTE   (Switzerland)

^d UPPSALA UNIVERSITY   (Sweden)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HEPARAN SULFATE; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPILIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN A 121; VASCULOTROPIN A 165; VASCULOTROPIN E; VASCULOTROPIN E NZ2; VASCULOTROPIN RECEPTOR 2; LIGAND; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SWINE; TRANSGENIC ANIMAL; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; LIGANDS; MICE; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPILIN-1; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERICYTES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; ZEBRAFISH;

EID: 55749110742     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-12-125856     Document Type: Article

References (50)

1. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signaling: in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359-371.
2. Matsumoto T, Bohman S, Dixelius J, et al. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 2005;24:2342-2353.
3. Takahashi T, Yamaguchi S, Chida K, Shibuya M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 2001;20:2768-2778.
4. Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci U S A. 2005;102:1076-1081.
5. Lamalice L, Houle F, Jourdan G, Huot J. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene. 2004;23:434-445.
6. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676.
7. Appleton BA, Wu P, Maloney J, et al. Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. EMBO J. 2007;26:4902-4912.
8. Pan Q, Chanthery Y, Wu Y, et al. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J Biol Chem. 2007;282: 24049-24056.
9. Fujisawa H, Kitsukawa T, Kawakami A, Takagi S, Shimizu M, Hirata T. Roles of a neuronal cell-surface molecule, neuropilin, in nerve fiber fasciculation and guidance. Cell Tissue Res. 1997;290:465-470.
10. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. Neuropilin is a semaphorin III receptor. Cell. 1997;90:753-762.
11. He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell. 1997;90:739-751.
12. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92:735-745.
13. Kawasaki T, Kitsukawa T, Bekku Y, et al. A requirement for neuropilin-1 in embryonic vessel formation. Development. 1999;126:4895-4902.
14. Pan Q, Chanthery Y, Liang WC, et al. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell. 2007;11:53-67.
15. Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 2002;71:435-471.
16. Jakobsson L, Kreuger J, Holmborn K, et al. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell. 2006;10:625-634.
17. Wise LM, Veikkola T, Mercer AA, et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci U S A. 1999;96:3071-3076.
18. Pieren M, Prota AE, Ruch C, et al. Crystal structure of the Orf virus NZ2 variant of vascular endothelial growth factor-E: implications for receptor specificity. J Biol Chem. 2006;281:19578-19587.
19. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269:26988-26995.
20. Scheidegger P, Weiglhofer W, Suarez S, et al. Vascular endothelial growth factor (VEGF) and its receptors in tumor-bearing dogs. Biol Chem. 1999;380:1449-1454.
21. Cébe-Suarez S, Grunewald FS, Jaussi R, et al. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR. FASEB J. 2008;22:3078-3086.
22. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002;248:307-318.
23. Nasevicius A, Larson J, Ekker SC. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast. 2000;17:294-301.
24. Landgren E, Schiller P, Cao Y, Claesson-Welsh L. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene. 1998;16:359-367.
25. Kreuger J, Lindahl U, Jemth P. Nitrocellulose filter binding to assess binding of glycosaminoglycans to proteins. Methods Enzymol. 2003;363:327-339.
26. Jakobsson L, Kreuger J, Claesson-Welsh L. Building blood vessels: stem cell models in vascular biology. J Cell Biol. 2007;177:751-755.
27. Weinstein BM. Plumbing the mysteries of vascular development using the zebrafish. Semin Cell Dev Biol. 2002;13:515-522.
28. Goishi K, Klagsbrun M. Vascular endothelial growth factor and its receptors in embryonic zebrafish blood vessel development. Curr Top Dev Biol. 2004;62:127-152.
29. Isogai S, Lawson ND, Torrealday S, Horiguchi M, Weinstein BM. Angiogenic network formation in the developing vertebrate trunk. Development. 2003;130:5281-5290.
30. Childs S, Chen JN, Garrity DM, Fishman MC. Patterning of angiogenesis in the zebrafish embryo. Development. 2002;129:973-982.
31. Lamalice L, Houle F, Huot J. Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/ p38 activation and endothelial cell migration in response to VEGF. J Biol Chem. 2006;281: 34009-34020.
32. Lali FV, Hunt AE, Turner SJ, Foxwell BM. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J Biol Chem. 2000;275:7395-7402.
33. Carmeliet P, Lampugnani MG, Moons L, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 1999;98:147-157.
34. Ruhrberg C, Gerhardt H, Golding M, et al. Spatially restricted patterning cues provided by heparin-binding VEGF-Acontrol blood vessel branching morphogenesis. Genes Dev. 2002;16:2684-2698.
35. Grunstein J, Masbad JJ, Hickey R, Giordano F, Johnson RS. Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol. 2000;20:7282-7291.
36. Lee S, Jilani SM, Nikolova GV, Carpizo D, IruelaArispe ML. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol. 2005;169: 681-691.
37. Springer ML, Banfi A, Ye J, et al. Localization of vascular response to VEGF is not dependent on heparin binding. FASEB J. 2007;21:2074-2085.
38. Dougher AM, Wasserstrom H, Torley L, et al. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors. 1997;14:257-268.
39. Gu C, Rodriguez ER, Reimert DV, et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell. 2003;5:45-57.
40. Lee P, Goishi K, Davidson AJ, Mannix R, Zon L, Klagsbrun M. Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci U S A. 2002;99:10470-10475.
41. Takahashi T, Fournier A, Nakamura F, et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell. 1999;99:59-69.
42. Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell. 1999;99:71-80.
43. Cai H, Reed RR. Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J Neurosci. 1999;19:6519-6527.
44. Wang L, Zeng H, Wang P, Soker S, Mukhopadhyay D. Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem. 2003;278:48848-48860.
45. Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol. 1999;146:233-242.
46. Shintani Y, Takashima S, Asano Y, et al. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 2006;25:3045-3055.
47. Vieira JM, Schwarz Q, Ruhrberg C. Selective requirements for NRP1 ligands during neurovascular patterning. Development. 2007;134:1833-1843.
48. Karihaloo A, Karumanchi SA, Cantley WL, Venkatesha S, Cantley LG, Kale S. Vascular endothelial growth factor induces branching morphogenesis/ tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion. Mol Cell Biol. 2005;25:7441-7448.
49. Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y, Bost F. Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie. 2006;88:1091-1098.
50. Matsumoto T, Turesson I, Book M, Gerwins P, Claesson-Welsh L. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol. 2002;156:149-160.